Summary of Intuitive Surgical Inc. Conference Call Company Overview - **Company**: Intuitive Surgical Inc. (NASDAQ: ISRG) - **Event**: Goldman Sachs 43rd Annual Global Healthcare Conference - **Date**: June 14, 2022 Key Industry Insights Procedure Recovery Post-COVID - In Q1, Intuitive Surgical experienced a **19% growth in procedures**, exceeding expectations despite the severe COVID outbreak with the Omicron variant [5] - Guidance for procedure growth was raised from **11%-15% to 12%-16%** due to recovery trends [5] - Historical correlation noted between COVID hospitalizations and surgical procedures, with expectations for this trend to continue [5] New Patient Formation and Cancer Procedures - Significant decline in procedures like colorectal colonoscopies and lung cancer screenings during the pandemic, with recovery not yet back to pre-COVID levels [8] - Backlog in cancer procedures exists, with some cases potentially progressing beyond treatable stages [8] Supply Chain and Inventory Management - Supply chain challenges remain, but the number of products affected by severe issues has decreased [10] - Inventory levels increased in Q1 as a proactive measure to manage supply constraints [10][12] Capital Spending Trends - Discussions around U.S. hospital capital spending indicate pressures from interest rates, inflation, and staffing [17] - Surgery remains a profit center for hospitals, with a focus on maintaining high-quality minimally invasive surgery (MIS) [17] Market Dynamics and Utilization Growth - Surgery demand is expected to persist even during economic downturns, with utilization growth driving new system sales [19] - Flexible acquisition models (leasing, per-procedure pricing) are being utilized to support high-quality MIS [19] Product Development and Innovation Industry Evolution and Robotics - Focus on improving surgical outcomes through robotics, data imaging, and mechatronics [21][22] - Emerging platform "Ion" for lung bronchoscopy is highlighted, with potential for earlier cancer detection and treatment [23] R&D Investment - R&D spending has doubled since 2017, focusing on multiple platforms (Xi, SP, Ion) and digital products [28][29] - Emphasis on improving surgical training and outcomes through data analysis and machine learning [30][31] Ambulatory Surgery Centers (ASCs) - ASCs are seen as a viable environment for robotic surgery, but financial pressures from reimbursement models need to be addressed [36] - The technology is adaptable to ASC settings, but efficiency and standardization are critical for success [36][38] Future Opportunities Imaging and Integration - Advances in imaging technology, such as real-time intraoperative imaging, are expected to enhance surgical outcomes [42] - Integration of imaging agents into robotic systems is in development, with a focus on improving cancer treatment [47][49] Ion System Performance - The Ion system has shown promising results in diagnostic yield for small lung lesions, with potential for single anesthesia events for biopsies and subsequent surgeries [51][53] Market Expansion - While currently focused on lung applications, there is potential for the Ion system to be adapted for other medical conditions in the future [56] Conclusion - Intuitive Surgical is navigating post-COVID recovery with strong procedure growth and proactive supply chain management - The company is heavily investing in R&D to enhance surgical outcomes and expand its product offerings, particularly in the robotic surgery space - Future growth opportunities exist in improving patient care pathways and expanding the use of robotic systems in various surgical settings

Intuitive Surgical, Inc. (NASDAQ:ISRG) Q1 2022 Earnings Conference Call April 21, 2022 4:30 PM ET Company Participants Brian King - Head, Investor Relations Gary Guthart - Chief Executive Officer Jamie Samath - Chief Financial Officer Conference Call Participants Amit Hazan - Goldman Sachs Rick Wise - Stifel Larry Biegelsen - Wells Fargo Drew Ranieri - Morgan Stanley Operator Ladies and gentlemen, thank you for standing by and welcome to the Intuitive Q1 2022 Earnings Release. At this time, all participants ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive Surgical, Inc. (Exact name of Registrant as specified in its Charter) Delaware 77-0416458 (State or Other Jurisd ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive Surgical, Inc. (Exact name of Registrant as specified in its Charter) Delaware 77-0416458 (State or ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) Q4 2021 Earning Conference Call January 20, 2022 4:30 PM ET Company Participants Brian King - Senior Director of Treasury and IR Gary Guthart - Chief Executive Officer Jamie Samath - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Tycho Peterson - JPMorgan Amit Hazan - Goldman Sachs Rick Wise - Stifel Matthew Taylor - UBS Operator Ladies and gentlemen, thank you for standing by, and welcome to the Intuitive Q4 2021 Earnings Release ...

Summary of Intuitive Surgical, Inc. Conference Call Company Overview - **Company**: Intuitive Surgical, Inc. (NASDAQ: ISRG) - **Event**: JPMorgan 40th Annual Healthcare Conference - **Date**: January 12, 2022 - **Participants**: Gary Guthart (CEO), Jamie Samath (CFO), Brian King (Senior Director of Treasury and IR) Key Points Industry and Market Context - Intuitive Surgical focuses on improving surgical outcomes through minimally invasive procedures, aiming for better patient experiences and lower treatment costs [2][3] - The company has been operational for over 25 years, with a vision for less invasive and more effective care [3] Performance Metrics - In 2021, over **1.5 million** da Vinci procedures were performed, totaling more than **10 million** cumulative procedures [3] - The installed base of da Vinci systems exceeded **6,700**, with **1,300** new installations in 2021 [3] - The company reported a **28%** growth in procedures in 2021, rebounding from the pandemic's impact [7] - The compound annual growth rate (CAGR) for procedures from 2019 to 2021 was **14%**, while the installed base grew at **10%** CAGR [8][9] Financial Guidance - For 2022, Intuitive Surgical projects a procedure growth range of **11% to 15%**, influenced by ongoing pandemic effects and supply chain disruptions [8][30] - The company anticipates continued growth in recurring revenue, which increased from **70%** in 2015 to **75%** in 2021 [9] Product and Service Development - The company is expanding its product offerings, including advanced instruments and digital tools, with a focus on enhancing surgical efficiency and outcomes [5][10] - The Ion flexible robotics program gained traction, particularly in lung biopsy applications, with promising clinical results [17][18] - The SP single port surgery system saw a **43%** growth in installed base and **56%** growth in procedures year-over-year for 2021 [19] Customer Engagement and Satisfaction - Intuitive Surgical's net promoter score (NPS) reached **72** in the U.S., indicating strong customer satisfaction [24] - The company emphasizes the importance of a comprehensive ecosystem that includes training, analytics, and economic validation to support customer needs [11][14] Challenges and Risks - The ongoing COVID-19 pandemic continues to impact surgical procedures and hospital staffing, creating uncertainty in growth projections [5][30] - Supply chain disruptions have been a significant challenge, although the company has managed these effectively [8][30] Strategic Focus - Intuitive Surgical is committed to investing in innovation and expanding its manufacturing capabilities to support global growth [25][35] - The company is exploring opportunities in emerging markets, particularly in Asia, and is focused on diversifying its growth beyond urology [25][45] Future Outlook - The company remains optimistic about long-term growth in the surgical and interventional market, with plans to introduce new technologies and expand existing product lines [26][25] - Intuitive Surgical is also looking into the potential of data aggregation and machine learning to enhance customer service and operational efficiency [72][74] Additional Insights - The company is actively working on economic validation programs to demonstrate the cost-effectiveness of robotic-assisted surgeries [47][50] - Intuitive Surgical is monitoring the impact of liquid biopsy technologies on surgical procedures, anticipating that early detection will enhance the attractiveness of surgical options [66][68] This summary encapsulates the key points discussed during the conference call, highlighting Intuitive Surgical's performance, strategic initiatives, and market outlook.

Intuitive Surgical, Inc. (NASDAQ:ISRG) Q3 2021Earnings Conference Call October 20, 2021 4:30 PM ET Company Participants Jamie Samath – Senior Vice President of Finance Gary Guthart – CEO Marshall Mohr – CFO Brian King – Treasurer Conference Call Participants Amit Hassan – Goldman Sachs Larry Biegelstein – Wells Fargo Bob Hopkins – Bank of America Tycho Peterson – JPMorgan Rick Wise – Stifel Matt Taylor – UBS Vijay Kumar – Evercore ISI Operator Ladies and gentlemen, thank you for standing by. Welcome to the ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) Morgan Stanley 19th Annual Global Healthcare Conference September 14, 2021 2:45 PM ET Corporate Participants Jamie Samath - Senior Vice President of Finance Phil Kim - Head of IR Conference Call Participants Drew Ranieri - Morgan Stanley Drew Ranieri Thank you everyone for joining us today for the Morgan Stanley Healthcare Conference, I’m Drew Ranieri, one of the medical device analyst here from Intuitive Surgical. I'm excited to have SVP of Finance, Jamie Samath and P ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) Wells Fargo 2021 Virtual Healthcare Conference September 10, 2021 12:40 PM ET Company Participants Marshall Mohr - Executive Vice President and Chief Financial Officer Philip Kim - Head of Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC Operator Welcome to the Wells Fargo Healthcare Conference. Before we get started, if you’re a member of the press or media, please disconnect at this time. This is a restricted line. Any una ...